The Role of Cetuximab in the Treatment of Metastatic Colorectal Cancer

被引:0
|
作者
Holubec, Lubos [1 ]
Liska, Vaclav [2 ]
Matejka, Vit M. [1 ]
Fiala, Ondrej [1 ]
Dreslerova, Jana [1 ]
Mrazkova, Petra [3 ,4 ]
Treska, Vladislav [2 ]
Finek, Jindrich [1 ]
机构
[1] Charles Univ Prague, Dept Oncol & Radiotherapy, Sch Med, Prague, Czech Republic
[2] Charles Univ Prague, Dept Surg, Sch Med, Prague, Czech Republic
[3] Charles Univ Prague, Dept Radiol, Sch Med, Prague, Czech Republic
[4] Charles Univ Prague, Teaching Hosp Pilsen, Prague, Czech Republic
关键词
KRAS; cetuximab; colorectal cancer; liver metastases; review; PLUS IRINOTECAN; 1ST-LINE TREATMENT; COMBINATION CHEMOTHERAPY; NEOADJUVANT CHEMOTHERAPY; LIVER METASTASES; OXALIPLATIN; FLUOROPYRIMIDINE; LEUCOVORIN; RESECTION;
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Targeted biological therapy is becoming a standard in personalized medicine for patients with advanced stages of cancer. Treatment with cetuximab, an anti-epidermal growth factor receptor (EGFR) antibody, represents an example of personalized anticancer the for patients with metastatic colorectal cancer and wild (non-mutated) type of the Kirsten rat sarcoma viral oncogene (KRAS). Here the role of cetuximab in treating metastatic colorectal cancer is discussed with a focus on the treatment of hepatic metastases.
引用
收藏
页码:4007 / 4011
页数:5
相关论文
共 50 条
  • [1] Emerging Role of Cetuximab in the Treatment of Colorectal Cancer
    Papa, Anselmo
    Rossi, Luigi
    Lo Russo, Giuseppe
    Giordani, Erika
    Spinelli, Gian Paolo
    Zullo, Angelo
    Petrozza, Vincenzo
    Tomao, Silverio
    RECENT PATENTS ON ANTI-CANCER DRUG DISCOVERY, 2012, 7 (02) : 233 - 247
  • [2] Cetuximab in metastatic colorectal cancer
    Broadbridge, Vy Tuong
    Karapetis, Cristos S.
    Price, Timothy Jay
    EXPERT REVIEW OF ANTICANCER THERAPY, 2012, 12 (05) : 555 - 565
  • [3] Role of cetuximab in first-line treatment of metastatic colorectal cancer
    Sotelo, Miguel Jhonatan
    Garcia-Paredes, Beatriz
    Aguado, Carlos
    Sastre, Javier
    Diaz-Rubio, Eduardo
    WORLD JOURNAL OF GASTROENTEROLOGY, 2014, 20 (15) : 4208 - 4219
  • [4] Cetuximab therapy in the treatment of metastatic colorectal cancer: The future frontier?
    Gomez, D.
    De Rosa, A.
    Addison, A.
    Brooks, A.
    Malik, H. Z.
    Cameron, I. C.
    INTERNATIONAL JOURNAL OF SURGERY, 2013, 11 (07) : 507 - 513
  • [5] Role of cetuximab and sorafenib in treatment of metastatic colorectal cancer
    Galal, K. M.
    Khaled, Z.
    Mourad, Abdel Monem M.
    INDIAN JOURNAL OF CANCER, 2011, 48 (01) : 47 - 54
  • [6] Cetuximab and Chemotherapy as Initial Treatment for Metastatic Colorectal Cancer
    Van Cutsem, Eric
    Koehne, Claus-Henning
    Hitre, Erika
    Zaluski, Jerzy
    Chien, Chung-Rong Chang
    Makhson, Anatoly
    D'Haens, Geert
    Pinter, Tamas
    Lim, Robert
    Bodoky, Gyoergy
    Roh, Jae Kyung
    Folprecht, Gunnar
    Ruff, Paul
    Stroh, Christopher
    Tejpar, Sabine
    Schlichting, Michael
    Nippgen, Johannes
    Rougier, Philippe
    NEW ENGLAND JOURNAL OF MEDICINE, 2009, 360 (14) : 1408 - 1417
  • [7] Cetuximab in the treatment of metastatic colorectal cancer
    Moosmann, Nicolas
    Heinemann, Volker
    EXPERT OPINION ON BIOLOGICAL THERAPY, 2007, 7 (02) : 243 - 256
  • [8] Cetuximab for treatment of metastatic colorectal cancer
    Cerea, G.
    Ricotta, R.
    Schiavetto, I.
    Maugeri, M. R.
    Sartore-Bianchi, A.
    Moroni, M.
    Artale, S.
    Siena, S.
    ANNALS OF ONCOLOGY, 2006, 17 : VII66 - VII67
  • [9] Cetuximab in the first-line treatment of K-ras wild-type metastatic colorectal cancer: the choice and schedule of fluoropyrimidine matters
    Ku, Geoffrey Y.
    Haaland, Benjamin A.
    Lopes, Gilberto de Lima, Jr.
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2012, 70 (02) : 231 - 238
  • [10] Standard chemotherapy with cetuximab for treatment of colorectal cancer
    Li, Xin-Xiang
    Liang, Lei
    Huang, Li-Yong
    Cai, San-Jun
    WORLD JOURNAL OF GASTROENTEROLOGY, 2015, 21 (22) : 7022 - 7035